Raymond James Financial’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
Other funds holding GLSI
Raymond James Financial's GLSI Position: Q3 2026 in Review
Raymond James Financial sold out of Greenwich LifeSciences (GLSI) in Q3 2026, closing a stake of 9,137 shares — an estimated $214K sold.
Raymond James Financial first reported a position in GLSI in Q2 2025 and held it in 3 quarters. The position peaked at $236K in Q1 2026. 53 funds tracked by Wall St. Rank hold GLSI as of Q3 2026.
- Raymond James Financial reported no remaining Greenwich LifeSciences position as of Q3 2026 after selling out during the quarter.
- Raymond James Financial sold 9,137 Greenwich LifeSciences shares in Q3 2026, an estimated $214K.
- Raymond James Financial first reported a position in Greenwich LifeSciences in Q2 2025 and held it in 3 quarters.
- Raymond James Financial's Greenwich LifeSciences position peaked at $236K in Q1 2026.
- 53 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.